Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic Dermatitis

Atopic Dermatitis Clinical Trial

Official title:

Comparison Between Asynchronous Online Care Model for the Management of Atopic Dermatitis With That of Face-to-Face, Office Visits

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00985894
• Other study ID #: 200917162
• Status: Completed
• Phase: N/A
• First received: September 25, 2009
• Last updated: May 24, 2017
• Start date: September 2009
• Est. completion date: March 2012

Study information

• Verified date: May 2017
• Source: University of California, Davis
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine if an asynchronous online model of teledermatology can achieve similar clinical outcomes as compared to conventional in-office care for the management of atopic dermatitis. The investigators also aim to determine the effects of this online care model on patient quality of life as well as patient and physician satisfaction.

The investigators' hypotheses include the following:

1. Compared to in-person visits, the online care model will result in similar clinical improvement in atopic dermatitis disease severity.

2. Compared to in-person visits, the online care model will result in similar improvements in quality of life.

3. Providers and subjects in the online group will achieve a similar level of overall satisfaction as those in the in-person group.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 183
• Est. completion date: March 2012
• Est. primary completion date: March 2012
• Accepts healthy volunteers: No
• Gender: All
• Age group: 4 Years and older

Eligibility

Inclusion Criteria:

• Patients aged 4 years or older at time of consent, may be male or female.

• Meet the Hanifin diagnostic criteria for atopic dermatitis.

• Capable of giving informed consent (for patients less than 18 years of age, assent will be obtained from the minor and informed consent will be obtained from a legal guardian).

• Able to image their skin or have someone do it for them.

• Able to adhere to the study visit schedule and other protocol requirements.

• Have access to a computer with internet connection, a digital camera, and an e-mail address.

Exclusion Criteria:

• Non English speaking patients.

• Patients requiring systemic treatment (e.g., cyclosporine, phototherapy).

• Patients requiring close laboratory monitoring.

Related Conditions & MeSH terms

• Atopic Dermatitis
• Dermatitis
• Dermatitis, Atopic
• Eczema

Intervention

Other:
• Online Teledermatology Care
Patients randomized to the intervention group will have their scheduled follow-up visits online via store and forward teledermatology.
• Conventional in Office Care
Patients randomized to the control group will have their scheduled follow-up visits via conventional in office care.

Locations

Country	Name	City	State
United States	UC Davis Department of Dermatology	Sacramento	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, Davis

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Eczema Area and Severity Index (EASI)		Every 8 weeks
Primary	Patient-oriented Eczema Measure (POEM)		Every 8 weeks